EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors

Letian Song, Shenghua Gao, Bing Ye, Mianling Yang, Yusen Cheng, Dongwei Kang, Fan Yi, Jin-Peng Sun, Luis Menéndez-Arias, Johan Neyts, Xinyong Liu, Peng Zhan

Acta Pharmaceutica Sinica B · 2024-01 · 14 (1) · 87-109

DOI: 10.1016/j.apsb.2023.08.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-01. Verfasst von Letian Song und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of …. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
  • Shenzhen Research Institute of Shandong University, Shenzhen 518057, China.
  • The Key Laboratory of Infection and Immunity of Shandong Province, Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, China.
  • Key Laboratory Experimental Teratology of the Ministry of Education, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, Ch…
  • Centro de Biología Molecular "Severo Ochoa" (Consejo Superior de Investigaciones Científicas & Autonomous University of Madrid), Madrid 28049, Spain.
  • KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven 3000, Belgium.

Zitieren

APA

Song, L., Gao, S., Ye, B., Yang, M., Cheng, Y., Kang, D., Yi, F., Sun, J. P., Menéndez-Arias, L., Neyts, J., Liu, X., & Zhan, P. (2024). Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors. Acta Pharmaceutica Sinica B, 14(1), 87-109. https://doi.org/10.1016/j.apsb.2023.08.004

Vancouver

Song L, Gao S, Ye B, Yang M, Cheng Y, Kang D, et al. Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors. Acta Pharmaceutica Sinica B. 2024;14(1):87-109. doi:10.1016/j.apsb.2023.08.004

BibTeX
@article{Song2024,
  author = {Song, Letian and Gao, Shenghua and Ye, Bing and Yang, Mianling and Cheng, Yusen and Kang, Dongwei and Yi, Fan and Sun, Jin-Peng and Menéndez-Arias, Luis and Neyts, Johan and Liu, Xinyong and Zhan, Peng},
  title = {Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2024},
  volume = {14},
  number = {1},
  pages = {87--109},
  doi = {10.1016/j.apsb.2023.08.004}
}
Kostenlos starten →